TMCnet News

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Integra LifeSciences Holdings Corporation (IART) on Behalf of Investors
[May 25, 2023]

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Integra LifeSciences Holdings Corporation (IART) on Behalf of Investors


Law Offices of Howard G. Smith continues its investigation on behalf of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART) investors concerning the Company's possible violations of federal securities laws.

On May 23, 2023, Integra disclosed that it had initiated a recall of its SurgiMed, PriMatrix, Revize, and TissueMend products manufactured at its Boston facility as far back as March 1, 2018. The Company attributed the recall to a finding that products may have been distributed with higher levels of endotoxins than permitted by the prduct specifications. As a result, the Company expects to write off approximately $22 million in inventory.



On this news, Integra's stock price fell $10.24, or 20.2%, to close at $40.48 per share on May 23, 2023, thereby injuring investors.

If you purchased Integra securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.


This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


[ Back To TMCnet.com's Homepage ]